In particular, the androgen receptor (AR) and estrogen receptor (ER) signaling pathways have been shown to contribute to bladder tumorigenesis and cancer progression (3–13), which may explain some of the differences in male versus female bladder cancer. This evidence concerns the gene ESR1 and urinary bladder cancer.